Key Event and Date
On August 17, 2026, Transchem Limited executed a Share Purchase Agreement with the existing shareholders of Greshma Shares and Stocks Limited (GSSL).
Transaction Details
The agreement was for the acquisition of 1,55,16,000 equity shares, representing 100% of the issued and paid-up equity share capital of GSSL.
Financial Consideration
The acquisition was completed for a total cash consideration of ₹25,91,17,200 (Indian Rupees Twenty-Five Crore Ninety-One Lakh Seventeen Thousand Two Hundred Only), which equates to ₹16.70 per share.
Resulting Corporate Structure
Upon completion of the acquisition on August 17, 2026, GSSL became a wholly-owned subsidiary of Transchem Limited. Prior to this transaction, Transchem held no shares in GSSL.
Related Party Status
The transaction is not a related party transaction. The promoters, promoter group, and group companies of Transchem have no direct or indirect interest in GSSL or its shareholders.
Target Company Profile
Greshma Shares & Stocks Limited (GSSL) is a Public Limited Company incorporated on August 12, 2009 (CIN: U74990MH2009PLC194870). Its registered office is at 124, Viraj, 41/42, 4th Floor, S. V. Road, Khar (W), Mumbai — 400052. It operates in the stock broking, capital markets, and financial services sector, with core activities in equity broking and depository services. It is a member of NSE (CM, F&O) and BSE (CM) and is a CDSL Depository Participant (DP).
Financials of GSSL
- Net Worth: ₹21.32 Crores (as on March 31, 2026)
- Annual Turnover:
- FY 2026: ₹5.98 Crores
- FY 2025: ₹11.32 Crores
- FY 2024: ₹9.47 Crores
Strategic Rationale
The acquisition is a strategic initiative for Transchem to enter the financial services sector in a comprehensive manner. The company intends to leverage GSSL's platform and expertise in stock broking to broaden its revenue base and create synergies for future expansion in this domain.
Regulatory Approvals Obtained
The acquisition required and received the following regulatory approvals and no-objection certificates for the change in control of GSSL, a SEBI-registered intermediary, all obtained prior to the SPA execution:
1. NSE Clearing Limited (NCL) – NOC dated January 5, 2026 (Ref. NCL/CMPL/2025/835)
2. National Stock Exchange of India Limited (NSE) – NOC dated March 16, 2026 (Ref. NSE/MEM-COMP/2026)
3. Indian Clearing Corporation Limited (ICCL) – approval dated March 24, 2026 (Ref. ICCL/MEM-INSP/2025-26/183)
4. BSE Limited – prior approval dated April 23, 2026 (Ref. BSE/MOD/AK/RBP/2026/30)
5. Central Depository Services (India) Limited (CDSL) – prior approval dated May 25, 2026 (Ref. CDSL/AC DP/AW/2026/121)
6. Securities and Exchange Board of India (SEBI) – prior approval dated June 19, 2026 (Ref. HO/38/38/16(30)2026-MIRSD-RAC1/14052/2026)
The SEBI approval was the final requirement under its single-window clearance mechanism.
Disclosure Compliance
The detailed disclosures are made in accordance with Regulation 30 and Schedule III of the SEBI Listing Regulations, read with SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
#Transchem #GreshmaShares #M&A #SEBIDisclosure #Regulation30 #FinancialServices #Positive